Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis - Top-Institutions - MDSpire

Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis

  • By

  • Feng Li

  • Jian Zhang

  • Xiangbo An

  • Jianfei Liu

  • Benkei Li

  • Haiwei Li

  • Li Jun

  • Ningfang Wang

  • Guinan Jiang

  • Ye Jiang

  • Dehui Zhang

  • Fei Gao

  • Lei Song

  • Jun Zhou

  • Wenheng Zheng

  • Min Ji

  • Feng Wang

  • June 1, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Erasmus MC Cancer Institute
    Erasmus MC Cancer Institute

    Rotterdam, Netherlands

    Key Differentiators

    • Hepatology

  • #2

    Sun Yat-sen University
    Sun Yat-sen University

    Guangzhou, China

    Key Differentiators

    • Hepatology

  • #3

    Spectrum Health
    Spectrum Health

    Grand Rapids, Michigan

    Key Differentiators

    • Hepatology

  • #4

    College of Human Medicine, Michigan State University
    College of Human Medicine, Michigan State University

    East Lansing, Michigan

    Key Differentiators

    • Hepatology

  • #5

    Hiroshima University
    Hiroshima University

    Hiroshima, Japan

    Key Differentiators

    • Hepatology

Original Source(s)

Balloon-occluded hepatic arterial infusion for unresectable hepatocellular carcinoma: a phase II trial interim analysis

  • by Feng Li, Jian Zhang, Xiangbo An, Jianfei Liu, Benkei Li, Haiwei Li, Li Jun, Ningfang Wang, Guinan Jiang, Ye Jiang, Dehui Zhang, Fei Gao, Lei Song, Jun Zhou, Wenheng Zheng, Min Ji, Feng Wang

  • June 1, 2026

Related Content

Engineered virus-hunter vaccine overcomes HBV immune tolerance

Lung Cancer Screening Prevalence and Changes in 2024

Use of PCSK9 Inhibitors Among Patients Receiving Immune Checkpoint Inhibitors for Cancer